Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma
Hao Wu, Wei Zhang, Zhenru Wu, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 2
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

DNA hypermethylation in disease: mechanisms and clinical relevance
Melanie Ehrlich
Epigenetics (2019) Vol. 14, Iss. 12, pp. 1141-1163
Open Access | Times Cited: 302
Crosstalk between miRNAs and DNA Methylation in Cancer
Michela Saviana, Patricia Le, Lavender Micalo, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1075-1075
Open Access | Times Cited: 32
Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissues
Viktoria Wagner, Fabian Kern, Oliver Hãhn, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 1, pp. 109-118
Open Access | Times Cited: 31
Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance
Chunjie Huang, Paniz Azizi, Masoud Vazirzadeh, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients
Neneng Ratnasari, Puji Lestari, Dede Renovaldi, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263298-e0263298
Open Access | Times Cited: 38
The role of noncoding RNAs in epithelial cancer
Massimiliano Agostini, Carlo Ganini, Eleonora Candi, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 41
MicroRNA signature in liver cancer
Soudeh Ghafouri‐Fard, Kasra Honarmand Tamizkar, Bashdar Mahmud Hussen, et al.
Pathology - Research and Practice (2021) Vol. 219, pp. 153369-153369
Closed Access | Times Cited: 40
The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation
Kurt Sartorius, Ping An, Cheryl A. Winkler, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
The Emerging Roles of Heterochromatin in Cell Migration
Gabi Gerlitz
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 37
E3 ubiquitin ligase TRIM31: A potential therapeutic target
Nian-Hua Deng, Zhen Tian, Ying-Jiao Zou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116846-116846
Open Access | Times Cited: 4
RETRACTED: lncRNA RMST Enhances DNMT3 Expression through Interaction with HuR
Wan-Xin Peng, Pratirodh Koirala, Wei Zhang, et al.
Molecular Therapy (2019) Vol. 28, Iss. 1, pp. 9-18
Open Access | Times Cited: 34
miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN
Sheng Xiao, Hongjia Zhu, Jian Luo, et al.
Oncology Reports (2019)
Open Access | Times Cited: 34
miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A
Songwei Feng, Shanhui Luo, Chenchen Ji, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 32
MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12
Shaoshan Han, Liang Wang, Liankang Sun, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 122, pp. 109754-109754
Open Access | Times Cited: 30
Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy
Mohammad Reza Karimzadeh, Peyman Pourdavoud, Naeim Ehtesham, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 3-4, pp. 157-174
Closed Access | Times Cited: 30
Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective
G Priyanka, Manoj Kumar Rajendran, Vidya P. Warrier, et al.
Cellular Signalling (2020) Vol. 78, pp. 109858-109858
Closed Access | Times Cited: 28
The Role of miR-29s in Human Cancers—An Update
Thuy T.P. Nguyen, Kamrul Hassan Suman, Thong Ba Nguyen, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2121-2121
Open Access | Times Cited: 19
MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight
Luis M. Ruiz‐Manriquez, Oscar Carrasco-Morales, E. Adrian Sanchez Z, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 19
miR‐143‐3p/TET1 Axis Regulates GPC1 Through DNA Methylation and Impairs the Malignant Biological Behaviour of HCC via the Hippo Signalling Pathway
Yan Liu, Di Du, Xue Gu, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
DNA Methylation Regulatory Axis miR‐29b‐3p/DNMT3B Regulates Liver Regeneration Process by Altering LATS1
Yinwen Zhou, Hao Wu, Qiu Wang, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 3
Open Access
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials
Roberto Piergentili, Stefano Sechi
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 471-471
Open Access
MiR-29c-3p May Promote the Progression of Alzheimer’s Disease through BACE1
Yanqun Cao, Xiangxiang Tan, Quzhe Lu, et al.
Journal of Healthcare Engineering (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 23
LncRNA LINC00511 Acts as an Oncogene in Colorectal Cancer via Sponging miR-29c-3p to Upregulate NFIA
Yinlong Hu, Ying Zhang, Meng Ding, et al.
OncoTargets and Therapy (2021) Vol. Volume 13, pp. 13413-13424
Open Access | Times Cited: 22
MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker
Xiang Jin, Li Zhu, Sheng Xiao, et al.
Molecular Medicine Reports (2021) Vol. 23, Iss. 5
Open Access | Times Cited: 21
Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
Geofrey Mahiki Mranda, Zhiping Xiang, Junjian Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top